Synergy CHC Corp. (NASDAQ:SNYR) Short Interest Update

Synergy CHC Corp. (NASDAQ:SNYR) was the target of a significant growth in short interest during the month of January. As of January 30th, there was short interest totaling 11,981 shares, a growth of 27.1% from the January 15th total of 9,426 shares. Based on an average daily trading volume, of 50,056 shares, the short-interest ratio is presently 0.2 days. Approximately 0.2% of the shares of the company are sold short. Approximately 0.2% of the shares of the company are sold short. Based on an average daily trading volume, of 50,056 shares, the short-interest ratio is presently 0.2 days.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the company. Geode Capital Management LLC acquired a new stake in shares of Synergy CHC during the 2nd quarter worth about $29,000. Virtu Financial LLC purchased a new position in shares of Synergy CHC during the third quarter valued at approximately $38,000. DRW Securities LLC acquired a new stake in Synergy CHC during the fourth quarter worth approximately $36,000. XTX Topco Ltd purchased a new stake in Synergy CHC in the 2nd quarter worth approximately $57,000. Finally, Warberg Asset Management LLC acquired a new stake in shares of Synergy CHC during the third quarter worth $82,000.

Synergy CHC Stock Performance

NASDAQ SNYR traded down $0.02 during trading hours on Monday, reaching $1.63. The company’s stock had a trading volume of 3,808 shares, compared to its average volume of 33,833. Synergy CHC has a fifty-two week low of $1.30 and a fifty-two week high of $4.25. The stock has a market cap of $18.34 million, a PE ratio of 5.62 and a beta of 3.47. The company’s 50-day moving average is $1.83 and its two-hundred day moving average is $2.27.

Synergy CHC (NASDAQ:SNYR) last released its quarterly earnings results on Thursday, November 13th. The company reported $0.01 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.01. Synergy CHC had a negative return on equity of 19.51% and a net margin of 7.77%.The company had revenue of $8.01 million during the quarter. Equities analysts expect that Synergy CHC will post 0.36 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently commented on the company. Ascendiant Capital Markets initiated coverage on Synergy CHC in a research note on Monday, February 2nd. They set a “buy” rating and a $5.00 price target for the company. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Synergy CHC in a report on Monday, December 29th. Wall Street Zen cut shares of Synergy CHC from a “buy” rating to a “hold” rating in a report on Saturday, November 8th. Finally, Roth Mkm lowered their price objective on Synergy CHC from $10.00 to $7.00 and set a “buy” rating on the stock in a report on Friday, November 14th. Two analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company. According to MarketBeat, Synergy CHC has an average rating of “Moderate Buy” and a consensus price target of $6.00.

Synergy CHC Company Profile

Synergy CHC Corp. engages in the marketing and distribution of branded health and wellness products. The company was founded on December 29, 2010 and is headquartered in Westbrook, ME.